Abstract:The Hippo pathway plays an evolutionarily conserved fundamental role in controlling organ size in multicellular organisms. Importantly, evidence from studies of patient samples and mouse models clearly indicates that deregulation of the Hippo signaling pathway plays a crucial role in the initiation and progression of many different types of human cancers. The Hippo signaling pathway is regulated by various stimuli, such as mechanical stress, G-protein coupled receptor signaling, and cellular energy status. When activated, the Hippo kinase cascade phosphorylates and inhibits the transcription co-activator YAP (Yes-associated protein), and its paralog TAZ (transcriptional coactivator with PDZ-binding motif), resulting in their cytoplasmic retention and degradation. When the Hippo signaling pathway is inactive, dephosphorylated YAP/TAZ translocate into the nucleus and activate gene transcription through binding to TEAD (TEA domain) family and other transcription factors. Such changes in gene expression promote cell proliferation and stem cell/progenitor cell self-renewal but inhibit apoptosis, thereby coordinately promote increase in organ size, tissue regeneration, and tumorigenesis. In this review, we summarize the molecular mechanisms of the mammalian Hippo signaling pathway with special emphasis on the Hippo kinase cascade and its upstream signals, the Hippo signaling pathway regulation of YAP and the mechanisms of YAP in regulation of gene transcription.

The Hippo-YAP signaling pathway and contact inhibition of growth

The Hippo-YAP Pathway in Organ Size Control and Tumorigenesis: an Updated Version.

Inactivation of Yap Oncoprotein by the Hippo Pathway is Involved in Cell Contact Inhibition and Tissue Growth Control

Molecular mechanisms of the mammalian Hippo signaling pathway.

The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal

Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway

Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway

The Hippo Pathway in Biological Control and Cancer Development

The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway.

Angiomotin is a Novel Hippo Pathway Component That Inhibits YAP Oncoprotein.

Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling

Role of the Hippo pathway and mechanisms for controlling cellular localization of YAP/TAZ

Hippo Signaling is Intrinsically Regulated During Cell Cycle Progression by APC/C Cdh1

YAP/TAZ for Cancer Therapy: Opportunities and Challenges (Review).

Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

YAP/TAZ for cancer therapy: Opportunities and challenges (Review)

The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease

The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment